Pharmacopeia
FLUCONAZOLE
Core pharmacology
- Class Group
ANTIFUNGAL:
AZOLE- Legacy Cicm Level
Level 3
- Introduction
Triazole
- Mechanism of action
fluorinated bis-triazole
reduction of ergosterol synthesis by inhibition of fungal cytochrome P450 enzymes (greater affinity for fungal than for human)- Antimicrobial Spectrum
Candida
Cryptococcus
Coccidia
(No activity against histoplasma, blasto, sporotrichosis, Aspergillus, mucormycosis)- Resistance Mechanism
Some candida species,
Decreased drug concentration
Target site alteration
Up-regulation of target enzyme
Development of bypass pathways- Adverse Effects Toxicity
N/V/D, Abdominal pain
Headache
Skin rash
Reversible alopecia
Rare: Hepatic failure, SJS
Should be avoided in Pregnancy
Drug interactions: (inhibitor of CYP3A4, CYP2C9)- Absorption
Well absorbed orally
- Distribution
good CSF penetration
- Metabolism
not metabolized well
- Excretion
Urine unchanged
- Special Points
potent CYP inhibitors with a wide range of drug interactions (including warfarin)